Evidence map›Paper›PMID 41076050›Full record

ArticleExperimental eye research2025

Impact of innate immune factors on the persistence of Staphylococcus aureus in the ocular environment.

Michelle C Callegan, Md Huzzatul Mursalin, Luis Longoria-Gonzalez, Roger Astley, Phillip S Coburn

Abstract read
In one paragraph

Article in Experimental eye research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michelle C CalleganDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Dean McGee Eye Institute, Oklahoma City, OK, USA. Electronic address: michelle-callegan@ou.edu.
Md Huzzatul MursalinDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Luis Longoria-GonzalezDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Roger AstleyDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Phillip S CoburnDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Dean McGee Eye Institute, Oklahoma City, OK, USA.

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Staphylococcus Biology in Ocular InfectionsR01EY032073 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C · 2021 to 2025
$1.8M
Targeting Chemokines in Intraocular InfectionR21EY028066 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C · 2019 to 2020
$399k
Targeting Innate Inflammation Pathways to Treat Ocular InfectionsR21EY035725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C · 2024 to 2025
$399k
NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY032073NEI NIH HHS R21 EY028066NEI NIH HHS R21 EY035725
6 · The paper itself

Abstract

Microbial keratitis can be detrimental to vision, causing corneal damage and inflammation that can lead to painful epithelial defects and scarring. Staphylococcus aureus is frequently isolated from bacterial keratitis cases. This organism's virulome and propensity for antibiotic resistance make it a formidable ocular pathogen that is often difficult to eradicate. S. aureus is not typically isolated from an immunocompetent ocular environment. We therefore hypothesized that elements of innate immunity are important in protecting the cornea from S. aureus infection, so their absence would facilitate persistence that might lead to keratitis. In the current study, we used a corneal scratch and topical inoculation model with S. aureus strain 8325-4 to infect mouse eyes and assess infection and inflammation in wild type C57BL/6J mice and mice genetically deficient in TLR2 (i.e. TLR2-/- or TLR2/4-/-) or TLR2-associated proinflammatory mediators (CXCL1-/-, CXCL2-/-, CXCL10-/-, CCL2-/-, CCL3-/-, or TNFα-/-). We included males and females in these experiments to determine whether sex was a biological variable. We assessed staphylococcal burden and clearance by quantifying colony forming units (CFU)/eye, inflammation by quantifying myeloperoxidase (MPO) from infiltrating neutrophils, and ocular pathology each day for 3-6 days, depending on the assay. Our data shows that, in general, the absence of the TLR2 pathway and its downstream mediators facilitated persistence of S. aureus in the mouse eye, but did not lead to ulcerative keratitis. S. aureus was cleared from the C57BL/6J mouse cornea within 3 days, while the organism persisted in knockout mouse eyes through day 6. Although pockets of staphylococci and neutrophil influx at the sites of infection were observed in some eyes, there were surprisingly very few corneal epithelial defects noted irrespective of mouse strain. These results suggest that defects in innate immunity create an environment that can facilitate persistence of S. aureus at the ocular surface, an area typically devoid of harmful bacteria.

Indexed as

CorneaEye Infections, BacterialImmunity, InnateKeratitisStaphylococcal InfectionsStaphylococcus aureusAnimalsDisease Models, AnimalFemaleMaleMiceMice, Inbred C57BLMice, KnockoutToll-Like Receptor 2Tlr2 protein, mouseToll-Like Receptor 2BacteriaCorneaInflammationKeratitisPersistenceStaphylococcus aureus

Identifiers

PMID41076050
PMCPMC12533500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.